Islet quality loss after isolation from brain-dead donors still hinders the implementation of human islet transplantation for treatment of type 1 diabetes. In this scenario, systemic inflammation elicited by donor brain death (BD) is among the main factors influencing islet viability and functional impairment. Exendin-4 is largely recognized to promote anti-inflammatory and cytoprotective effects on β-cells. Therefore, we hypothesized that administration of exendin-4 to brain-dead donors might improve islet survival and insulin secretory capabilities. Here, using a rat model of BD, we demonstrate that exendin-4 administration to the brain-dead donors increases both islet viability and glucose-stimulated insulin secretion. In this model, exendin-4 treatment produced a significant decrease in interleukin-1β expression in the pancreas. Furthermore, exendin-4 treatment increased the expression of superoxide dismutase-2 and prevented BD-induced elevation in uncoupling protein-2 expression. Such observations were accompanied by a reduction in gene expression of two genes often associated with endoplasmic reticulum (ER) stress response in freshly isolated islets from treated animals, C/EBP homologous protein and immunoglobulin heavy-chain binding protein. As ER stress response has been shown to be triggered by and to participate in cytokine-induced β-cell death, we suggest that exendin-4 might exert its beneficial effects through alleviation of pancreatic inflammation and oxidative stress, which in turn could prevent islet ER stress and β-cell death. Our findings might unveil a novel strategy to preserve islet quality from brain-dead donors. After testing in the human pancreatic islet transplantation setting, this approach might sum to the ongoing effort to achieve consistent and successful single-donor islet transplantation.
Introduction
Pancreatic islet transplantation has emerged as a promising treatment for type 1 diabetes mellitus (Ryan et al., 2005; Shapiro et al., 2000 Shapiro et al., , 2006 . However, long-term insulin independence can only be achieved if a high islet mass (i.e., 10,000-14,000 islet equivalents per kilogram of recipient' body weight) is transplanted . Patients with labile diabetes, who experience frequent oscillations in blood glucose levels, usually leading to episodes of hypoglycemia, often benefit from grafts with partial function. Improvement in glycemic control and hypoglycemia awareness are normally observed in patients transplanted with a sub-optimal islet mass (Leitao et al., 2008) . However, the ultimate goal of long-term insulin independence usually requires more than one organ donor. Therefore, most recipients receive islets from two or three donors, limiting the number of transplantations and, consequently, the number of patients benefiting from this therapy (Fiorina et al., 2008) . For those reasons, developing new strategies to prevent islet quality loss during the isolation procedure is a topic of great interest.
Brain death (BD) exerts an important negative impact on deceased-donor organ quality (Pratschke et al., 1999) . This impact has been demonstrated in various organs such as the liver, kidney, and heart (Pratschke et al., 2001; Shivalkar et al., 1993; Weiss et al., 2007) . In rat pancreatic islets, BD has been shown to reduce both viability and function after isolation, probably through an increase in pro-inflammatory cytokines (Contreras et al., 2003) . Furthermore, our group has previously shown that BD induces inflammation in human pancreatic tissue (Rech et al., 2014) . Inflammation is known to mediate β-cell death and participates in the pathogenesis of both type 1 and type 2 diabetes (Eizirik and Mandrup-Poulsen, 2001 ). Accumulating evidence also points to a role for inflammation in triggering production of reactive oxygen species (ROS) and oxidative damage to β-cells (Barbu et al., 2002; Chen et al., 2005; Tabatabaie et al., 2003) .
Glucagon-like peptide-1 (GLP1) analogs have been approved as a therapy for type 2 diabetes, since they increase insulin secretion, decrease glucagon production and delay gastric empting (Drucker and Nauck, 2006) . Anti-inflammatory and cytoprotective properties of GLP1 analogs, acting directly on β-cells, have been supported by many studies. Such analogs have been shown to prevent β-cell apoptosis triggered by different stimuli such as lipotoxicity, pro-inflammatory cytokines, glucocorticoids and streptozotocin (Ferdaoussi et al., 2008; Li et al., 2003; Natalicchio et al., 2013; Ranta et al., 2006) . Many molecular mechanisms and intracellular signal transduction pathways are believed to be involved in the protective actions of GLP1 analogs. Upon ligand binding, the GLP1 receptor activates adenylyl cyclase, increasing intracellular cAMP levels, which in turn activates protein kinase A (PKA). Regarding the metabolic actions of GLP1 analogs on β-cells, PKA activation and subsequent phosphorylation of its downstream targets is the primary pathway for potentiation of glucose-dependent insulin secretion (Kaihara et al., 2013) . However, cAMP signaling also activates targets involved in the cytoprotective actions of GLP1 analogs (Jhala et al., 2003) . In fact, several studies have reported anti-inflammatory actions of cAMP signaling on β-cells and other cell types (Pugazhenthi et al., 2010) . Remarkably, the transcription factor cAMP response elementbinding protein (CREB) is activated upon cAMP signaling and promotes the expression of numerous genes associated with cell survival during stress conditions. Furthermore, the GLP1 analog exendin-4 has been shown to induce activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which play important roles in cell survival, proliferation, insulin secretion, and protection against apoptosis (Cechin et al., 2012) . Another cellular process implicated in β-cell death is the endoplasmic reticulum (ER) stress response (Huang et al., 2007; Kharroubi et al., 2004; Oyadomari et al., 2001) . Interestingly, GLP1 receptor agonists also protect β-cells from cytotoxicity promoted by ER stress-inducing agents (Cunha et al., 2009; Tsunekawa et al., 2007) .
We hypothesized that, due to its cytoprotective properties, the administration of exendin-4 to a brain-dead donor might improve islet quality parameters, which are important to improving islet transplantation success rates. In the present study, we demonstrate that exendin-4 administration following BD increases isolated islets viability and function, which are accompanied by attenuation of pancreatic gene expression of interleukin-1 beta and stress-related genes.
Materials and methods

Animals
Male Wistar rats (weight, 300-350 g) fed with a standard laboratory diet were used throughout the study. All animals were kept in the animal facility of Hospital de Clínicas de Porto Alegre (Porto Alegre, state of Rio Grande do Sul, Brazil) and received care according to the NIH Guide for the Care and Use of Laboratory Animals (National Research Council US, 2011). The study was approved by the local ethics committee for the use of animals in research.
Experimental design
Animals were randomized into three experimental groups: control (no central nervous system injury); BD (brain death induced experimentally); and BD+Ex-4 [BD induced experimentally, followed by immediate intraperitoneal administration of exendin-4 (Exenatide; Eli Lilly, Indianapolis, IN, USA), 5 μg/kg body weight]. A schematic diagram outlining the experimental procedures is shown in Fig. 1A . First, animals were anesthetized with a mixture of 2% isoflurane (Biochimico, Itatiaia, Brazil) in oxygen using a precision vaporizer (Takaoka, model 1415, Sao Paulo, Brazil) . Then, they were intubated using a plastic cannula from a 16-gauge catheter (Abbocath ® ; Abbott Laboratories, Abbott Park, IL, USA), and mechanically ventilated using a volumetric ventilator (Harvard Rodent Ventilator, model 683; Harvard Apparatus Co., Millis, MA, USA) with a tidal volume of 2.5 mL and frequency of 85 strokes per minute. Arterial blood pressure was monitored continuously through cannulation of the left femoral artery, attached to a Biopac MP100 data acquisition system (Biopac Systems Inc., Goleta, CA, USA). Brain death was induced using a modified version of the method previously published by Takada et al. (1998) . Briefly, a hole was drilled at the left fronto-lateral region of the animal's skull to permit the passage of a No. 4 Fogarty catheter (Fogarty Arterial Embolectomy Catheter, 4F; Edwards Lifesciences, Irvine, CA, USA) without direct cerebral damage. The balloon was then rapidly inflated with 0.5 mL of saline for 1 minute. Animals in the control (sham-operated) group had the catheter inserted but not inflated. Maximally dilated pupils, apnea and the absence of palpebral reflexes confirmed the BD condition. Body temperature was maintained at 37°C by means of a heated table. Six hours was allowed to elapse prior to either pancreas biopsy or collagenase perfusion for islet isolation.
Islet isolation and dispersion
Islet isolation was performed following the protocol suggested by Carter et al. (2009) . After 6 hours of mechanical ventilation, the bile duct was cannulated to allow pancreatic perfusion with 10 mL of cold Hank's balanced salt solution (HBSS, Sigma-Aldrich, Saint Louis, Missouri, USA) containing 0.5 mg/mL of collagenase P (Roche Diagnostics, Mannheim, Germany). The perfused pancreas was removed and digested for 15 minutes at 37°C. Digestion was stopped by the addition of RPMI 1640 medium (11 mmol/L glucose), supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, 0.1 mg/mL streptomycin, and 25 mmol/L HEPES (Gibco Life Technologies, Gaithersburg, MD, USA). Islet purification was performed in a Histopaque (Sigma-Aldrich) density gradient using 1.119, 1.100, and 1.077 g/mL density layers. An aliquot of purified islets was counted in islet equivalent (IEQ) numbers under a microscope with a scaled reticle. One IEQ was defined as the islet mass equivalent to a spherical islet 150 μm in diameter. After isolation, islets were immediately washed with HBSS and stored at −80°C for protein and RNA extraction. When dispersion was needed, islets were digested with 0.125% Trypsin-EDTA (Gibco Life Technologies) for 5 minutes at 37°C. Digestion was stopped by addition of supplemented RPMI 1640 medium and the resulting islet single-cell suspension immediately evaluated for viability or nuclear chromatin staining. For glucose-stimulated insulin secretion (GSIS) assays, islets were rested for 3 hours in supplemented RPMI 1640 at 37°C in a humidified atmosphere of 95% air and 5% CO2 prior to static incubations.
Islet viability
Upon fluorescein diacetate (FDA) and propidium iodide (PI) staining, living cells actively convert the non-fluorescent FDA into the green fluorescent compound fluorescein, while dead cells show red fluorescence in their nuclei due to penetration of PI through the permeabilized membrane. To bypass the limitation of this method to evaluate viability in intact islets (Boyd et al., 2008) , we used dispersed islet cells to perform viability assessment. For this purpose, FDA-PI staining was used to distinguish dead from viable single cells. Freshly dispersed islet cells were stained with 5 μg/mL FDA and 5 μg/mL PI (Sigma-Aldrich) and immediately analyzed under an Axio Imager A2 fluorescent microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). One thousand cells from each animal were counted and the percentages of viable and dead cells were estimated. Images were acquired using a digital camera (Zeiss -Axio Cam HRc ® ) and Axio Vision software (Carl Zeiss Microscopy GmbH).
Glucose-stimulated insulin secretion (GSIS)
Glucose-stimulated insulin secretion was performed on freshly isolated islets after resting them for 3 hours in supplemented RPMI Results are expressed as mean ± S.E.M. (n = 3); *P < 0.05. 5% CO2. Briefly, 15 islets were transferred into 1 mL of Krebs-Ringerbicarbonate buffer (KRB, 137 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2.5 mM CaCl2, 25 mM NaHCO3, 0.25% BSA, 2.8 mM glucose), in triplicates, and incubated for 30 minutes at 37°C as discussed earlier. The medium was removed and replaced with 1 mL of fresh KRB, followed by 1 hour of incubation under the same conditions (basal glucose stimulation). The medium was then removed, stored for insulin measurement, and replaced by 1 mL of KRB containing 28 mM glucose (high glucose stimulation). After an additional 1 hour of incubation, the medium was collected and stored for insulin measurement. Islet DNA was extracted by boiling the samples in 100 μL of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) for 20 minutes, and total DNA was quantified using Quanti-iT PicoGreen (Invitrogen Life Technologies, Gaithersburg, MD, USA). Secreted insulin in the medium was quantified with a commercial rat insulin ELISA kit (Millipore, Billerica, MA, USA), following manufacturer instructions. Secreted insulin was normalized by total DNA and expressed as pg insulin/ng DNA/hour. For stimulation index (SI) assessment, the ratio of high to basal glucose stimulation was calculated.
Quantitative RT-qPCR
RNA was extracted from islets and pancreatic tissue using an RNeasy Mini Kit (Qiagen, Chatsworth, CA) and was reversetranscribed using a SuperScript ® VILO™ cDNA Synthesis Kit (Invitrogen Life Technologies), following manufacturer' protocols. Quantitative PCR was performed by monitoring the increase in fluorescence of Fast SYBR ® Green Master Mix (Invitrogen Life Technologies) (Higuchi et al., 1993) . Rat-specific primer sequences for the genes Il-1β, tumor necrosis factor-α (Tnf-α), chemokine (C-C motif) ligand 2 (Ccl2), tissue factor (Tf), C/EBP homologous protein (Chop), immunoglobulin heavy-chain binding protein (Hspa5/Bip), superoxide dismutase 2 (Sod2), uncoupling protein 2 (Ucp2), and β-actin (Actb) were designed using Primer Express 3.0 software (Life Technologies) and are represented in Table 1 . All the reactions were performed in a Viia TM 7 real time PCR system (Life Technologies). Relative mRNA expressions were calculated through the standard curve method (Wong and Medrano, 2005) using Actb as the reference gene. Quantitative RT-PCR specificity was determined using melting curve analyses and all primers generated amplicons that produced a single sharp peak during the analyses.
Immunoblotting
Protein extracts from freshly isolated islets were resolved on 12% polyacrylamide gels, transferred to Immobilon ® -P SQ membranes (Millipore), and incubated with monoclonal antibodies to active caspase-3, total ERK1/2, phosphoERK1/2 (Thr202/Tyr204) (Cell Signaling Technology, Beverly, MA, USA) and α-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Secondary antibodies consisted of horseradish peroxidase conjugated goat anti-mouse or antirabbit antibodies (Millipore). Detection was performed using Immobilon Western Chemiluminescent HRP Substrate (Millipore). Images were acquired in an ImageQuant LAS 500 (GE Healthcare, Piscataway, NJ, USA) digital imaging system and band densitometry analysis was performed using ImageJ 1.47v (National Institutes of Health, USA). In order to have a positive control for caspase-3 activation, islets were cultured for 48 hours in standard culture conditions in the presence or absence of a cytokine mix containing the recombinant human cytokines IL-1β, TNF-α and IFN-γ at 50, 1000 and 100 U/mL respectively (Gibco Life Technologies).
Immunohistochemistry
Pancreata were removed, fixed in 10% phosphate buffered formalin, embedded in paraffin, sectioned (4 μm thick), and immunostained after deparaffinization and rehydration. For active caspase-3 staining, slides were incubated with a primary antibody (Cell Signaling Technology) and then with a biotinylated secondary antibody, streptavidin-horseradish peroxidase conjugate, and diaminobenzidine tetrahydrochloride (DAB; Dako Cytomation, Inc., Carpinteria, CA, USA). Quantification was performed by digital image analyses using Image Pro Plus 4.5 software (Media Cybernetics, Bethesda, MD, USA). Images were acquired using a Cool Snap-Pro CS (Media Cybernetics) camera attached to a Zeiss microscope (model AXIOSKOP-40; Carl Zeiss Microscopy GmbH). Islets were cropped from the original images in order to consider only staining within the cells of interest. The area of each islet was calculated and recorded using ImageJ 1.47v (National Institutes of Health). Two independent blinded investigators (R.C. and N.E.L.) analyzed the intensity of brown-colored immunostaining in pixels. A Pearson's correlation coefficient of r = 0.83 was obtained between the two observers. The mean number of pixels identified by the two investigators normalized by the islet area was used to quantify caspase-3 activation in 10 islets from each animal.
Immunofluorescence and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay
For insulin staining, slides were incubated with anti-insulin primary antibody (Dako Cytomation) followed by a tetramethylrhodamine (TRITC)-conjugated anti-guinea pig secondary antibody (SigmaAldrich). Slides were then mounted with medium containing 4′,6-diamidino-2-phenylindole, dilactate (DAPI; Sigma-Aldrich) for nucleus staining. For the TUNEL assay, following deparaffinization and rehydration, slides were assayed with a commercial In Situ Cell Death Detection Kit (Roche Diagnostics), following the manufacturers protocol. For positive control purposes, slides were pre-treated with one unit of DNAse I for 15 minutes at 37°C to generate double-stranded DNA breaks. Both immunofluorescence and in situ TUNEL assays were analyzed under an Axio Imager A2 fluorescent microscope (Carl Zeiss Microscopy GmbH). Images were acquired using a digital camera (Zeiss -Axio Cam HRc ® ) and Axio Vision software (Carl Zeiss Microscopy GmbH). Table 1 Oligonucleotide primers used for quantitative RT-PCR analyses.
Target
Forward and reverse sequences
Il-1β, interleukin-1 beta; Tnf-α, tumor necrosis factor; Ccl2, chemokine (C-C motif) ligand 2; Tf, tissue factor; Chop, C/EBP homologous protein; Hspa5, immunoglobulin heavy-chain binding protein; Sod2, superoxide dismutase 2; Ucp2, uncoupling protein 2; Actb, β-actin.
Nuclear chromatin staining
Freshly dispersed islet cells were stained with 10 μg/mL Hoechst 33342 (Sigma-Aldrich) for 10 minutes at 37°C, as described elsewhere (Riachy et al., 2002) . To quantify apoptosis, 1000 nuclei were counted per animal and apoptotic cells were identified by the presence of condensed or fragmented nuclei. Again, counting and image acquisition were performed under an Axio Imager A2 fluorescent microscope, attached to a digital camera, with the aid of the Axio Vision software (Carl Zeiss Microscopy GmbH).
Caspase-Glo 3/7 assay
After isolation, islets were immediately frozen and protein extracts were obtained and quantified. Then, 10 μg of total protein lysates was assayed for caspase 3 and caspase 7 activities by the Caspase-Glo 3/7 assay (Promega Corporation, Madison, WI, USA) following manufacturer instructions.
Statistical analysis
Variables are described as mean ± S.E.M. Variables with nonnormal distribution were log-transformed. Differences across groups were tested using ANOVA with a Tukey post-hoc test. Statistical significance was set at P < 0.05 (two-tailed). All analyses were performed using SPSS 18 (IBM, Armonk, NY, USA).
Results
Exendin-4 prevents loss of islet cell viability induced by brain death
Islet viability >80% is among the product release criteria for human islet transplantation (Davide Mineo et al., 2010) . Brain death has previously been shown to promote loss of islet cell viability (Contreras et al., 2003) . To evaluate the effect of exendin-4 administration on single-cell viability, we assayed dispersed islet cells by FDA-PI staining. Islets originated from BD animals showed a decrease in viability (proportion of FDA-positive cells) as compared with control islets from sham-operated animals. Administration of exendin-4 following the induction of BD protected pancreatic islets against the viability loss observed in the BD group (control, 86.6% ± 4.85%; BD, 59.8% ± 15.46%; BD+Ex-4, 91.6% ± 0.57%, P < 0.05; Fig. 1B) . Accordingly, in BD group-derived islets, we observed a significant 3-fold increase in the proportion of dead cells (positively stained by PI). This phenomenon was also reversed by exendin-4 treatment (Fig. 1C) . Fig. 1D depicts representative fluorescence micrographs from the three experimental groups.
Brain death has been previously shown to impact islet recovery after purification (Contreras et al., 2003) . We quantified postpurification islet recovery from all three experimental groups, although no statistically significant differences were observed (control, 910 ± 266; BD, 865 ± 378; BD+Ex-4, 728 ± 391 IEQs/ pancreas, P = 0.81).
Brain death impairs glucose-stimulated insulin secretion, and exendin-4 treatment minimizes this effect
Functionality of pancreatic islets, as estimated by their ability to secrete insulin in response to glucose stimulation, has also been shown to be impaired after BD (Contreras et al., 2003) . We investigated the ability of exendin-4 to protect islets against BD-induced dysfunction. For this purpose, insulin secretion was evaluated by static incubation experiments at two glucose concentrations: basal (2.8 mM glucose) and stimulated (28 mM glucose). At basal glucose stimulation conditions, insulin secretion did not differ statistically among groups. However, when islets were stimulated at 28 mM glucose, insulin secretion from the BD group was reduced as compared with both control and exendin-4 treated groups (control, 0.88 ± 0.1; BD, 0.56 ± 0.07; BD+Ex-4, 0.83 ± 0.07, pg insulin/ng DNA/hour, P < 0.01; Fig. 2A ). The stimulation index, which represents the insulin secretion ratio (stimulated/ basal), also differed among groups. Again, islets derived from the BD group exhibited impaired insulin secretion when compared with control-group islets, and exendin-4 administration was able to protect against the damage caused by BD (control, 6.2 ± 0.41; BD, 5.1 ± 0.6; BD+Ex-4, 6.1 ± 0.35, P < 0.05; Fig. 2B ).
The activation status of ERK1/2, the most downstream member of the mitogen-activated protein kinase (MAPK) pathway, is essential for insulin gene expression and secretion in response to glucose (Wijesekara et al., 2010) . In addition, several reports have demonstrated the ability of GLP1 analogs to promote ERK1/2 phosphorylation/activation in β-cells (Egan et al., 2003) . Thus, we assessed the phosphorylation status of ERK1/2 in islets isolated from the three experimental groups. Donor treatment with exendin-4 significantly increased the phosphorylation states of both ERK1 and ERK2 ( Fig. 2C and 2E ).
Brain death increases mRNA expression of pro-inflammatory cytokines in the pancreas, and exendin-4 treatment partially prevents this effect
Brain death has been shown to induce gene expression of proinflammatory cytokines in different organs, including the pancreas (Contreras et al., 2003; Takada et al., 1998) . We hypothesized that an inflammatory pancreatic environment could be the underlying mechanism of BD-induced impairment in β-cell function and viability. Thus, we assessed pancreatic mRNA expression of Il-1β and Tnf-α, two cytokines widely associated with β-cell death. Pancreata from BD animals exhibited significantly increased Il-1β and Tnf-α gene expression as compared with control animals (Fig. 3A and 3B , respectively). Exendin-4 treatment completely blocked this increase in Il-1β expression, but produced no significant effect on Tnf-α expression. We also assessed the expression of Ccl2 and Tf, two genes whose expressions are associated with the instant blood-mediated inflammatory reaction (IBMIR) in the transplantation setting (Saito et al., 2010) . No significant difference in pancreatic mRNA expression for these two genes was found among groups (Ccl2: control, 1.00 ± 0.57; BD, 1.74 ± 1.00; BD+Ex-4, 1.38 ± 0.87, P = 0.90 and Tf: control, 1.00 ± 0.22; BD, 1.35 ± 0.47; BD+Ex-4, 1.15 ± 0.66, P = 0.66). Gene expression of Il-1β, Tnf-α, Ccl2 and Tf was also evaluated in freshly isolated islets, and no significant differences were observed among groups (data not shown).
Exendin-4 promotes pancreatic expression of Sod2 and prevents brain death-induced increase in Ucp2
Oxidative stress is believed to play a role in BD-induced organ damage (Morariu et al., 2008) . In this context, exendin-4 has recently been shown to have interesting antioxidant properties (Padmasekar et al., 2013) . This prompted us to investigate pancreatic expression of two oxidative stress-related genes, Sod2 and Ucp2, in our experimental model. Both genes were elevated in BD as compared to control animals ( Fig. 4A and 4B ). Exendin-4 treatment further up-regulated gene expression of Sod2 (Fig. 4A) , which encodes the mitochondrial antioxidant enzyme superoxide dismutase 2. In contrast, Ucp2, which was significantly increased in BD animals, returned to control levels in the exendin-4 treated group (Fig. 4B) .
Chop and Hspa5 gene expression is augmented in islets from brain-dead animals, and exendin-4 treatment protects against this effect
Several studies have demonstrated that ER stress may contribute to cytokine-mediated β-cell death [reviewed in Eizirik et al., 2008] . Exendin-4 has been shown to protect β-cells from ER stress (Cunha et al., 2009; Tsunekawa et al., 2007) . This prompted us to investigate the association between BD and islet expression of Chop and Hspa5, two genes known to be up-regulated in ER stress and widely used as markers of this phenomenon, as well as the effect of exendin-4 on this scenario. We found that mRNA expression of both genes was elevated in islets originated from BD animals ( Fig. 5A and 5B). Treatment with exendin-4 protected islets against this elevation in ER stress-related genes.
Brain death-induced loss of viability is not elicited by classic apoptosis
In an attempt to evaluate the extent to which BD promotes islet apoptosis, we performed an immunoblotting for active caspase-3 on freshly isolated islets from three animals in each experimental group. Surprisingly, caspase-3 activity was below the limit of detection in all animals (Fig. 6A) . To obtain a positive control for the experimental system, we treated islets with a cytokine mix as described in Section 2. Fig. 5B shows clear activation of caspase-3 upon exposure to cytokines, suggesting that in the BD model used herein, there is no caspase-3 activation and, consequently, no evidence of classic apoptosis. To confirm this finding, we performed immunohistochemistry for active caspase-3 on pancreas biopsy specimens from six animals in each experimental group. No statistically Fig. 2 . Exendin-4 treatment promotes isolated islets function and ERK1/2 phosphorylation. Following isolation, islets rested for 3 hours before GSIS experiments were performed by static incubations as described in Section 2. For determination of ERK1/2 phosphorylation, whole-cell lysates from freshly isolated islets were immunoblotted for total and phospho ERK1/2. A, Results from basal and high glucose incubations are represented in pg insulin/ng DNA/hour. B, Mean stimulation indexes are shown for all groups. C, Immunoblotting analysis of total and phospho ERK1/2. D,E, Relative quantification of ratios phospho ERK1/total ERK1 and phospho ERK2/total ERK2 respectively. All results are expressed as mean ± S.E.M. (n = 3); # P < 0.1; *P < 0.05; **P < 0.01. significant difference was found among groups using this method ( Fig. 7A and 7B) . We also counted the appearance of condensed nuclei on dispersed islet cells from all groups by analyzing Hoechst 33342-stained cells under fluorescence microscopy. Again, no significant differences were observed among groups ( Fig. 7C and 7D ). Contreras et al., using a different rat model of BD, reported that TUNEL staining is increased in the pancreatic tissue of BD donors (Contreras et al., 2003) . Conversely, in our model, no increase in TUNEL staining was observed in response to BD (Fig. 7E) . To determine the overall impact of BD on islet architecture and insulin content, we performed insulin immunofluorescence in tissue sections from animals of all experimental groups. Danobeitia et al. recently demonstrated that BD promotes loss of insulin staining and morphological integrity of islets in a non-human primate model of BD (Danobeitia et al., 2014 ). In our model, however, no such alterations were apparent prior to islet isolation (Fig. 7F) . Finally, islet protein extracts from control and BD animals were assayed for caspase-3 and caspase-7 activities using the Caspase-Glo 3/7 assay (Fig. 7G) . No significant differences were observed among groups. Altogether, our data suggest that the cell death observed following 6 hours of BD is not classical apoptosis.
Discussion
In our experimental model, BD induced loss of islet viability and function. These outcomes were associated with an increase in mRNA gene expression of the pro-inflammatory cytokines Il-1β and Tnf-α, as well as the oxidative stress-related genes Sod2 and Ucp2 in pancreatic tissue. Additionally, ER stress response-related genes were augmented in islets isolated from brain-dead donors. Interestingly, exedin-4 treatment after BD induction was able to improve islet function and viability, which was accompanied by a decrease in Il-1β, Chop and Hspa5. Furthermore, exedin-4 treatment further enhanced the expression of Sod2, a mitochondrial antioxidant enzyme, and prevented the BD-induced increase in Ucp2.
The Edmonton protocol, proposed by Shapiro et al. (Ryan et al., 2005; Shapiro et al., 2000 Shapiro et al., , 2006 , demonstrated that human islet transplantation is a feasible therapeutic alternative for type 1 diabetes. However, the scarcity of available islets for transplantation restricts the adoption of this alternative in routine clinical practice. Although a few centers have reported success in transplanting recipients with islets from a single donor (Hering et al., 2005; Koh et al., 2010) , the general need for multiple donors still hinders the Relative mRNA expression of Sod2 (A) and Ucp2 (B) were assessed in the pancreases of animals from all experimental groups by quantitative real time PCR. Results are expressed as mean fold change in comparison with control animals using Actb as endogenous control. Bars represent mean ± S.E.M. (n = 5); *P < 0.05; **P < 0.01. advance of islet transplantation as a treatment option. Many approaches have been developed to prevent islet mass loss during isolation, culture, transplantation and post-transplantation stages (Shapiro, 2011) . Nonetheless, no single intervention has emerged as a method to effectively enhance the success of single-donor islet transplantation.
There is strong evidence in support of an involvement of donor' BD in organ quality loss (Contreras et al., 2003; Pratschke et al., 1999 Pratschke et al., , 2001 Rech et al., 2014; Shivalkar et al., 1993; Weiss et al., 2007) . Use of living-donor pancreatas for islet transplantation demonstrated that insulin independency could be attained with as little as a half-pancreas islet preparation (Matsumoto et al., 2005) . This provides indirect evidence that the donor' BD is, indeed, highly associated with the need for multiple donors to achieve insulin independency. However, living-donor islet transplantation is an extreme measure, because it can be associated with significant donor morbidity. In this context, strategies minimizing the deleterious effects of BD have the potential to improve clinical islet transplantation outcomes.
Early organ-donor management strategies have been used in transplantation centers and are associated with increased organ procurement (Rech et al., 2013) . In general, protocols focus on hemodynamic and hormonal control; however, no approach focusing on specific pancreatic protection has been evaluated clinically. One study, using a rat model of gradual-onset BD demonstrated that 17β-estradiol administration could improve islet quality (Eckhoff et al., 2004) , although this strategy still awaits clinical investigation. Recently, a study by Danobeitia et al. demonstrated that pre-treatement with an IL-1 receptor antagonist attenuated inflammation and improved islet function in a non-human primate BD model (Danobeitia et al., 2014) . This study and ours represent an important proof of concept for the hypothesis that brain-dead donor treatment with anti-inflammatory and β-cell protective agents may improve postisolation islet function. Exendin-4 and Liraglutide, another GLP1 analog, have been shown to benefit islet transplantation outcomes when added to islet culture and/or administered to recipients (Faradji et al., 2009; Merani et al., 2008; Toso et al., 2010) . Based on our findings, exendin-4 has the potential to improve islet transplantation outcomes when administered to the organ donor prior to pancreas procurement. With this strategy, islet damage could be prevented, probably allowing availability of a larger islet mass for transplantation. It is possible that islet viability and function benefits observed in this study may not translate into long-term graft survival in vivo. Thus, future research evaluating transplantation outcomes both in animal models and in a clinical setting must be done before the suggested donor management strategy can be adopted in clinical practice.
In accordance with our gene expression analyses, we hypothesize that the cytoprotective effects of exendin-4 observed here operate, at least in part, through a mechanism involving attenuation of pancreatic inflammation and oxidative stress. However, one cannot rule out that BD could affect vascular stability and expose pancreatic islets to hypoxic conditions. In this scenario, exendin-4 could minimize islet cell death, thereby reducing macrophage infiltration and, consequently, inflammation. Thus, the data presented here cannot distinguish between a model in which inflammation is directly caused by BD and one which inflammation is a secondary effect caused by clearance of dying hypoxic cells by infiltrating macrophages. As shown in Fig. 3A , a major increase in Il-1β expression in the pancreas occurs upon BD. This elevation in Il-1β expression was completely abrogated in animals receiving exendin-4. Our data also show that expression of another pro-inflammatory cytokine, Tnf-α, is increased as a consequence of BD. In contrast to 6 . Assessment of caspase-3 activation on freshly isolated islets suggests that brain death does not induce apoptotic cell death. Whole-cell lysates from freshly isolated islets were immunoblotted for active caspase-3 with α-tubulin as a loading control. A, Immunoblotting of three islet preparations from each experimental group is presented. Caspase-3 activation was below detection limit in all preparations. B, Islets were cultured in the presence or absence of a cytokine mix (50 U/mL IL-1β, 1000 U/mL TNF-α and 100 U/mL IFN-γ) for 48 hours to serve as positive control for caspase-3 activation.
its effect on Il-1β, exendin-4 treatment had no effect on Tnf-α expression. In vitro studies have revealed that TNF-α has less pronounced β-cell death-promoting properties than IL-1β (Ortis et al., 2012) . In our experimental setting, Tnf-α seems to play no important role in the islet-protective mechanism of exendin-4. Future studies are necessary to determine why exendin-4 treatment affected Il-1β, but did not changed Tnf-α expression. BD has been shown to promote intra-islet macrophage infiltration (Danobeitia et al., 2014) , and exendin-4 treatment might affect infiltration of specific immune cell populations. In agreement with this hypothesis, exendin-4 has previously been shown to mitigate monocyte infiltration and expression of adhesion molecules in a mouse model of atherosclerosis (Arakawa et al., 2010) . Thus, future research could investigate whether exendin-4 affects the dynamics of immune cells infiltration in the pancreatic tissue of brain-dead donors.
IL-1β promotes β-cell death in a variety of experimental systems. Therefore, the decrease in its expression in the pancreatic environment could suffice to exert a positive impact on islet survival. This cytokine can activate various intracellular signaling pathways involved in β-cell death (Eizirik and Mandrup-Poulsen, 2001 ). One mechanism more recently demonstrated to take part in IL-1β-induced β-cell death is the ER stress response (Cardozo et al., 2005) . Thus, we decided to evaluate both the pancreatic milieu to which the islets are exposed and a more downstream event, intrinsic to the islets, which is known to occur upon cytokine signaling (the ER stress response). It is worth mentioning that exendin-4 has been shown to protect β-cells from ER stress (Cunha et al., 2009; Tsunekawa et al., 2007) . In this study, we demonstrated for the first time that islet expression of Chop and Hspa5, two important components of the ER stress response, increases upon BD. More importantly, this increase is prevented by exendin-4 treatment ( Fig. 5A and 5B). Chop and Hspa5 are commonly used in the literature as markers of ER stress; however, their expression could also be increased by other types of cellular stresses that can promote phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2α), such as amino acid deprivation, the presence of doublestranded RNA and heavy metals (Wek et al., 2006) . Therefore, they are not specific indicators of ER stress. In the particular case of β-cells, previous studies have demonstrated that IL-1β alone can promote inositol-requiring enzyme 1 (IRE-1α) mediated X-box binding protein 1 (Xbp-1) alternative splicing, an event specifically activated during the ER stress response (Cardozo et al., 2005) . Considering that our model produced a significant increase in pancreatic Il-1β expression, we suggest that increased expression of Chop and Hspa5 following BD could be an evidence of ER stress response activation in isolated islet cells.
Our data also suggest a role of BD in triggering pancreatic oxidative stress. Many lines of evidence suggest that ROS production in response to a variety of stimuli, including pro-inflammatory cytokines, promotes β-cell death and GSIS impairment (Tabatabaie et al., 2003) . We sought to investigate the expression of two antioxidant genes, Sod2 and Ucp2, known to be upregulated in oxidative stress conditions (Pi et al., 2010) . Sod2 encodes a mitochondrial manganese superoxide dismutase with an important role in protection against oxidative damage, and is induced by pro-inflammatory cytokines (Darville et al., 2000) . Ucp2 encodes uncoupling protein-2, which controls mitochondrial-derived ROS production. In addition, numerous studies have demonstrated a negative link between Ucp2 expression and β-cell function (Robson-Doucette et al., 2011) . Expression of both genes was augmented in the pancreas of BD animals (Fig. 4) , indicating a compensatory mechanism to counterbalance the increase in oxidative stress due to BD. Interestingly, exendin-4 treatment further exacerbated Sod2 expression, which was accompanied by a reduction in Ucp2. Our data are consistent with the findings of a previous study, which showed that increased superoxide levels induced Ucp2 expression and that such activation promoted β-cell dysfunction (Krauss et al., 2003) . The higher levels of Sod2 observed in animals treated with exendin-4 supposedly potentiated superoxide clearance, presumably preventing activation of Ucp2 in the BD group.
Our findings raise a debate regarding the type of islet cell death triggered by BD. Contreras et al. (2003) suggested that BD induces apoptotic cell death of islet cells. Two pieces of evidence were presented to support this supposition: TUNEL assay results and quantification of DNA fragmentation by ELISA showed an increase in islet-cell apoptosis induced by BD. This conclusion was based on the assumption that DNA fragmentation is a hallmark of apoptotic cell death. However, DNA fragmentation also occurs in necrotic cell death (Dong et al., 1997) , and TUNEL labeling of dead cells does not specifically indicate the underlying mechanism of death (Grasl-Kraupp et al., 1995) . We were not able to reproduce the TUNEL assay results reported by Contreras et al. (Fig. 7E) . Currently, the gold standard marker of apoptotic cell death is activation of caspase-3, which is involved in the execution phase of both intrinsic and extrinsic apoptosis pathways. In the present study, assessment of caspase-3 activation, both in situ by immunohistochemistry and in isolated islets by immunoblotting and using the caspase-Glo assay, did not detect any significant difference between BD and control animals (Figs. 6, 7A and 7G) . Quantification of condensed nuclei, another hallmark of apoptotic cell death, showed no difference among group, corroborating the other findings of this study (Fig. 7B) . Recently, careful dissection of the biochemical mechanisms involved in β-cell death induced mainly by IL-1β suggested that the primary type of death is not classical apoptosis. It does not involve caspase-3 activation, at least in the initial 6 hours of exposure (Collier et al., 2006 (Collier et al., , 2011 , and causes release of high mobility group box 1 (HMGB1) (Steer et al., 2006) , a protein selectively released by cells undergoing necrosis. Our data support the hypothesis that the type of cell death that β-cells undergo after 6 hours of BD plus isolation stress is necrosis and not classical apoptosis. It is worth mentioning that, after long-term exposure (e.g., 48 hours), cytokines can effectively induce caspase-3 activation (Fig. 6B) . We found that BD causes a 3-fold increase in the number of PI-stained cells with intact nuclei (Fig. 1B) . PI only enters cells with compromised membrane integrity, a hallmark of either necrotic cell death or latestage apoptosis. Microscopic examination can easily discriminate necrotic from late apoptotic cells. Necrotic cells display intact nuclei, whereas late apoptotic cells exhibit fragmented nuclei. In our analyses, the number of cells with PI-stained fragmented nuclei was negligible. Moreover, the absence of statistically significant differences in caspase-3 activation indicates that the loss of cell viability observed in the BD group probably did not occur through apoptotic cell death.
Altogether, our findings demonstrate the potential of exendin-4 as a protective agent for pancreatic islets when administered to the deceased organ donor prior to organ procurement. After thorough evaluation in clinical trials, incorporation of this strategy in the clinical setting might add to the ongoing effort to attain consistent and successful single-donor islet transplantation for the treatment of type 1 diabetic patients. designed the study and contributed to discussion. D.C. designed the study and reviewed/edited the manuscript. R.C. and D.C. are joint guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
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